Literature DB >> 8074655

Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene.

R Tazawa1, X M Xu, K K Wu, L H Wang.   

Abstract

Prostaglandin H synthase (PGHS) is the rate-limiting enzyme in the conversion of arachidonic acid to prostanoids. The human PGHS has two isoforms. PGHS-1 is a house keeping gene whereas PGHS-2 is an inducible gene. We reported here the isolation of the entire PGHS-2 gene and its 5'-flanking region from a human bacteriophage P1 genomic library. The gene containing 10 exons is 7.5 kb in length and located at chromosome 1. The transcriptional start site was mapped at 134 bases upstream from the ATG start codon. Nucleotide sequence of 1.8 kb promoter region contains a TATA box and a number of potential regulatory elements including CRE, NF-kappa B, Sp1 and AP2 sites. Studies of the promoter activity showed that the first 460 nucleotides of 5'-flanking region efficiently drove transcription of the luciferase reporter gene in human umbilical vein endothelial cells upon stimulation with phorbor ester.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8074655     DOI: 10.1006/bbrc.1994.2167

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  62 in total

1.  Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate.

Authors:  X M Xu; L Sansores-Garcia; X M Chen; N Matijevic-Aleksic; M Du; K K Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  Therapeutic targets for hypoxia-elicited pathways.

Authors:  C T Taylor; S P Colgan
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

Review 3.  Cyclooxygenase- and lipoxygenase-mediated DNA damage.

Authors:  N Speed; I A Blair
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

4.  Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.

Authors:  Frank Batista; Daniel Vaiman; Jean Dausset; Marc Fellous; Reiner A Veitia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

5.  Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma.

Authors:  Hikmet Akkız; Süleyman Bayram; Aynur Bekar; Ersin Akgöllü; Yakup Ülger
Journal:  Mol Cell Biochem       Date:  2010-11-02       Impact factor: 3.396

6.  Transcription factor Ets-1 inhibits glucose-stimulated insulin secretion of pancreatic β-cells partly through up-regulation of COX-2 gene expression.

Authors:  Xiong-Fei Zhang; Yi Zhu; Wen-Biao Liang; Jing-Jing Zhang
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

7.  Homeobox protein CDX2 reduces Cox-2 transcription by inactivating the DNA-binding capacity of nuclear factor-kappaB.

Authors:  Hiroyuki Mutoh; Hiroko Hayakawa; Hirotsugu Sakamoto; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

Review 8.  Does cyclooxygenase-2 affect blood pressure?

Authors:  Hui-Fang Cheng; Raymond C Harris
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

9.  Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cells.

Authors:  William E Ackerman; Brad H Rovin; Douglas A Kniss
Journal:  Biol Reprod       Date:  2004-08-25       Impact factor: 4.285

10.  Role of cyclooxygenase-2 functional gene polymorphisms in Helicobacter pylori induced gastritis and gastric atrophy.

Authors:  B R Achyut; Uday C Ghoshal; Nikhil Moorchung; Balraj Mittal
Journal:  Mol Cell Biochem       Date:  2008-09-30       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.